---
figid: PMC7461616__ijms-21-05845-g001
figlink: pmc/articles/PMC7461616/figure/ijms-21-05845-f001/
number: Figure 1
caption: 'Targeting lipid metabolism of myeloid cells in cancer immunotherapy. Pharmacological
  modulation of molecular regulators of lipid metabolism in tumor-associated macrophages
  (TAM), monocytic (M-) and granulocytic (PMN-) myeloid-derived suppressor cells (MDSC)
  showed efficacy in dampening tumor immunosuppression and improving cancer immunotherapies:
  immune checkpoint blockade; adoptive cell transfer; cytokines administration or
  modulation; cancer vaccines; reprogramming of polarized inflammation in myeloid
  cells. Abbreviations: LXR, liver X receptor; ACAT1, acetyl-CoA acetyltransferase
  1; COX2, cyclooxygenase 2; FATP2, fatty acid transport protein 1; PPARγ, peroxisome
  proliferator-activated receptor γ; PD-1, programmed-death protein 1; PD-L1, PD-1
  ligand; CTLA4, cytotoxic T-lymphocyte antigen 4; CPT1a, carnitine palmitoyltransferase
  1a; CAR T/M, chimeric antigen receptor T cell/Macrophage; TCR T, T cell receptor-engineered
  T cell; NK, natural killer; CB, cholesterol biosynthesis; IFN, interferon; STING,
  stimulator of interferon genes; TLR, Toll-like receptor; GM-CSF, granulocyte-macrophage
  colony-stimulator factor; FAS, fatty acid synthesis; MSR1, macrophage scavenger
  receptor 1; DC, dendritic cell; SIRP1α, signal regulatory protein 1α; CSF1, macrophage
  colony-stimulating factor; CSF1R, CSF1 receptor; PI3K, phosphoinositide 3-kinase;
  HDAC, histone deacetylases; C5aR, complement component 5 receptor; PDE5, phosphodiesterase
  5; COX2, cyclooxygenase 2; PGE2, prostaglandin E2; CCR5, chemokine receptor 5; ATRA,
  all-trans retinoic acid; TEV, tumor-derived extracellular vesicles; RTK, receptor
  tyrosine kinase. Text in brackets represents examples of drugs targeting the molecule
  or pathway of reference. Dashed arrows and question marks underline controversial
  or not fully clarified evidence.'
pmcid: PMC7461616
papertitle: 'Lipid Metabolism and Cancer Immunotherapy: Immunosuppressive Myeloid
  Cells at the Crossroad.'
reftext: Augusto Bleve, et al. Int J Mol Sci. 2020 Aug;21(16):5845.
pmc_ranked_result_index: '55206'
pathway_score: 0.7858564
filename: ijms-21-05845-g001.jpg
figtitle: Targeting lipid metabolism of myeloid cells in cancer immunotherapy
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7461616__ijms-21-05845-g001.html
  '@type': Dataset
  description: 'Targeting lipid metabolism of myeloid cells in cancer immunotherapy.
    Pharmacological modulation of molecular regulators of lipid metabolism in tumor-associated
    macrophages (TAM), monocytic (M-) and granulocytic (PMN-) myeloid-derived suppressor
    cells (MDSC) showed efficacy in dampening tumor immunosuppression and improving
    cancer immunotherapies: immune checkpoint blockade; adoptive cell transfer; cytokines
    administration or modulation; cancer vaccines; reprogramming of polarized inflammation
    in myeloid cells. Abbreviations: LXR, liver X receptor; ACAT1, acetyl-CoA acetyltransferase
    1; COX2, cyclooxygenase 2; FATP2, fatty acid transport protein 1; PPARγ, peroxisome
    proliferator-activated receptor γ; PD-1, programmed-death protein 1; PD-L1, PD-1
    ligand; CTLA4, cytotoxic T-lymphocyte antigen 4; CPT1a, carnitine palmitoyltransferase
    1a; CAR T/M, chimeric antigen receptor T cell/Macrophage; TCR T, T cell receptor-engineered
    T cell; NK, natural killer; CB, cholesterol biosynthesis; IFN, interferon; STING,
    stimulator of interferon genes; TLR, Toll-like receptor; GM-CSF, granulocyte-macrophage
    colony-stimulator factor; FAS, fatty acid synthesis; MSR1, macrophage scavenger
    receptor 1; DC, dendritic cell; SIRP1α, signal regulatory protein 1α; CSF1, macrophage
    colony-stimulating factor; CSF1R, CSF1 receptor; PI3K, phosphoinositide 3-kinase;
    HDAC, histone deacetylases; C5aR, complement component 5 receptor; PDE5, phosphodiesterase
    5; COX2, cyclooxygenase 2; PGE2, prostaglandin E2; CCR5, chemokine receptor 5;
    ATRA, all-trans retinoic acid; TEV, tumor-derived extracellular vesicles; RTK,
    receptor tyrosine kinase. Text in brackets represents examples of drugs targeting
    the molecule or pathway of reference. Dashed arrows and question marks underline
    controversial or not fully clarified evidence.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL2
  - TMEM173
  - CSF2
  - TLR8
  - TLR7
  - FAS
  - IL7
  - IL15
  - TRA
  - TRB
  - TRD
  - TRG
  - CARTPT
  - TLR9
  - PDCD1
  - CD274
  - CCR2
  - CD40
  - CTLA4
  - Rosiglitazone
  - Etomoxir
  - TCR
  - CpG
  - CCX782-B
  - IPI-594
  - Celecoxib
  - PGE2
  - ATRA
  - Omeprazole
  - Sutinib
  - Metformin
  - Biguanides
  - TAM
genes:
- word: IL-2
  symbol: IL-2
  source: hgnc_alias_symbol
  hgnc_symbol: IL2
  entrez: '3558'
- word: IFNS/STING
  symbol: STING
  source: hgnc_alias_symbol
  hgnc_symbol: TMEM173
  entrez: '340061'
- word: GM-CSF
  symbol: GM-CSF
  source: hgnc_alias_symbol
  hgnc_symbol: CSF2
  entrez: '1437'
- word: TLR7/8
  symbol: TLR8
  source: hgnc_symbol
  hgnc_symbol: TLR8
  entrez: '51311'
- word: TLR7/8
  symbol: TLR7
  source: hgnc_symbol
  hgnc_symbol: TLR7
  entrez: '51284'
- word: FAS
  symbol: FAS
  source: hgnc_symbol
  hgnc_symbol: FAS
  entrez: '355'
- word: IL-7
  symbol: IL-7
  source: hgnc_alias_symbol
  hgnc_symbol: IL7
  entrez: '3574'
- word: IL-15
  symbol: IL-15
  source: hgnc_alias_symbol
  hgnc_symbol: IL15
  entrez: '3600'
- word: (+IL-2)
  symbol: IL2
  source: hgnc_symbol
  hgnc_symbol: IL2
  entrez: '3558'
- word: IL-2)
  symbol: IL2
  source: hgnc_symbol
  hgnc_symbol: IL2
  entrez: '3558'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: CART
  symbol: CART
  source: hgnc_alias_symbol
  hgnc_symbol: CARTPT
  entrez: '9607'
- word: TLR9
  symbol: TLR9
  source: hgnc_symbol
  hgnc_symbol: TLR9
  entrez: '54106'
- word: PD-1/PD-L1
  symbol: PD-1
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1
  entrez: '5133'
- word: PD-1/PD-L1
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: Anti-CCL2/CCR2
  symbol: CCR2
  source: hgnc_symbol
  hgnc_symbol: CCR2
  entrez: '729230'
- word: CD40
  symbol: CD40
  source: hgnc_symbol
  hgnc_symbol: CD40
  entrez: '958'
- word: CTLA4
  symbol: CTLA4
  source: hgnc_symbol
  hgnc_symbol: CTLA4
  entrez: '1493'
chemicals:
- word: Rosiglitazone
  source: MESH
  identifier: C089730
- word: Etomoxir
  source: MESH
  identifier: C054207
- word: TCR
  source: MESH
  identifier: D017260
- word: CpG
  source: MESH
  identifier: C024660
- word: CCX782-B
  source: MESH
  identifier: C585356
- word: IPI-594
  source: MESH
  identifier: C078466
- word: Celecoxib
  source: MESH
  identifier: C105934
- word: PGE2
  source: MESH
  identifier: D015232
- word: ATRA
  source: MESH
  identifier: D014212
- word: Omeprazole
  source: MESH
  identifier: D009853
- word: Sutinib
  source: ''
  identifier: ''
- word: Metformin
  source: MESH
  identifier: D008687
- word: Biguanides
  source: MESH
  identifier: D001645
- word: TAM
  source: MESH
  identifier: C419191
diseases: []
---
